Docking of the centrosome at the plasma membrane directs lytic granules to the immunological synapse. To identify signals controlling centrosome docking at the synapse, we have studied cytotoxic T lymphocytes (CTLs) in which expression of the T cell receptor-activated tyrosine kinase Lck is ablated. In the absence of Lck, the centrosome is able to translocate around the nucleus toward the immunological synapse but is unable to dock at the plasma membrane. Lytic granules fail to polarize and release their contents, and target cells are not killed. In CTLs deficient in both Lck and the related tyrosine kinase Fyn, centrosome translocation is impaired, and the centrosome remains on the distal side of the nucleus relative to the synapse. These results show that repositioning of the centrosome in CTLs involves at least two distinct steps, with Lck signaling required for the centrosome to dock at the plasma membrane.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044125PMC
http://dx.doi.org/10.1083/jcb.201008140DOI Listing

Publication Analysis

Top Keywords

immunological synapse
12
plasma membrane
12
centrosome
8
centrosome docking
8
lck signaling
8
lytic granules
8
tyrosine kinase
8
dock plasma
8
synapse
5
lck
5

Similar Publications

Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor control exhibited by 4-1BB.ζ-CART.

View Article and Find Full Text PDF

Cytotoxic lymphocytes are crucial to our immune system, primarily eliminating virus-infected or cancerous cells via perforin/granzyme killing. Perforin forms transmembrane pores in the plasma membrane, allowing granzymes to enter the target cell cytosol and trigger apoptosis. The prowess of cytotoxic lymphocytes to efficiently eradicate target cells has been widely harnessed in immunotherapies against haematological cancers.

View Article and Find Full Text PDF

A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action.

Front Immunol

January 2025

Amgen Research, Amgen Inc., South San Francisco, CA, United States.

Article Synopsis
  • Tolerogenic vaccines aim to create immune tolerance specifically for disease-related antigens, offering a safer alternative to broad immunosuppression, which can lead to infections and weakened anti-tumor responses.
  • They work by promoting certain immune cells that help regulate and suppress harmful immune responses, thus targeting conditions like autoimmunity and transplant rejection.
  • The design of these vaccines varies, often involving a relevant antigen paired with a tolerogenic adjuvant that enhances their effectiveness by creating a more favorable immune response through multiple mechanisms.
View Article and Find Full Text PDF

Ferroptosis and autophagy are closely associated with Alzheimer's disease (AD). Elevated ferric ion levels can induce oxidative stress and chronic inflammatory responses, resulting in brain tissue damage and further neurological cell damage. Autophagy in Alzheimer's has a dual role.

View Article and Find Full Text PDF

New frontiers about retinal cell transplantation for retinal degenerative diseases start from the idea that acting on stem cells can help regenerate retinal layers and establish new synapses among retinal cells. Deficiency or alterations of synaptic input and neurotrophic factors result in trans-neuronal degeneration of the inner retinal cells. Thus, the disruption of photoreceptors takes place.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!